ArticleJournal of translational medicine2026

NK cell infusion is well-tolerated and shows preliminary efficacy in patients with recurrent hepatocellular carcinoma post-liver transplantation : a phase I trial.

Fan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.